Tissue-Based Diagnostics Market, Global Outlook and Forecast 2023-2029

Report ID: MMG197639 | Category: Service & Software | Pages: 64 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Tissue-Based Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue-Based Diagnostics. This report contains market size and forecasts of Tissue-Based Diagnostics in global, including the following market information:
Global Tissue-Based Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Tissue-Based Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunohistochemistry (IHC) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tissue-Based Diagnostics include Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, ABCAM, Merck, BD and Hologic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tissue-Based Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tissue-Based Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Tissue-Based Diagnostics Market Segment Percentages, by Type, 2022 (%)
    Immunohistochemistry (IHC)
    In Situ Hybridization (ISH)
    Digital Pathology and Workflow Management
    Special Staining
Global Tissue-Based Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Tissue-Based Diagnostics Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Research Laboratories
    Pharmaceutical Companies
    Contract Research Organizations
    Other
Global Tissue-Based Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Tissue-Based Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tissue-Based Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tissue-Based Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Roche
    Danaher
    Thermo Fisher Scientific
    Abbott
    Agilent Technologies
    ABCAM
    Merck
    BD
    Hologic
    Bio Rad
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tissue-Based Diagnostics, market overview.
Chapter 2: Global Tissue-Based Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Tissue-Based Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tissue-Based Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Tissue-Based Diagnostics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Tissue-Based Diagnostics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Tissue-Based Diagnostics Overall Market Size
    2.1 Global Tissue-Based Diagnostics Market Size: 2022 VS 2029
    2.2 Global Tissue-Based Diagnostics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Tissue-Based Diagnostics Players in Global Market
    3.2 Top Global Tissue-Based Diagnostics Companies Ranked by Revenue
    3.3 Global Tissue-Based Diagnostics Revenue by Companies
    3.4 Top 3 and Top 5 Tissue-Based Diagnostics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Tissue-Based Diagnostics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Tissue-Based Diagnostics Players in Global Market
        3.6.1 List of Global Tier 1 Tissue-Based Diagnostics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Tissue-Based Diagnostics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Tissue-Based Diagnostics Market Size Markets, 2022 & 2029
        4.1.2 Immunohistochemistry (IHC)
        4.1.3 In Situ Hybridization (ISH)
        4.1.4 Digital Pathology and Workflow Management
        4.1.5 Special Staining
    4.2 By Type - Global Tissue-Based Diagnostics Revenue & Forecasts
        4.2.1 By Type - Global Tissue-Based Diagnostics Revenue, 2018-2023
        4.2.2 By Type - Global Tissue-Based Diagnostics Revenue, 2024-2029
        4.2.3 By Type - Global Tissue-Based Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Tissue-Based Diagnostics Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Research Laboratories
        5.1.4 Pharmaceutical Companies
        5.1.5 Contract Research Organizations
        5.1.6 Other
    5.2 By Application - Global Tissue-Based Diagnostics Revenue & Forecasts
        5.2.1 By Application - Global Tissue-Based Diagnostics Revenue, 2018-2023
        5.2.2 By Application - Global Tissue-Based Diagnostics Revenue, 2024-2029
        5.2.3 By Application - Global Tissue-Based Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Tissue-Based Diagnostics Market Size, 2022 & 2029
    6.2 By Region - Global Tissue-Based Diagnostics Revenue & Forecasts
        6.2.1 By Region - Global Tissue-Based Diagnostics Revenue, 2018-2023
        6.2.2 By Region - Global Tissue-Based Diagnostics Revenue, 2024-2029
        6.2.3 By Region - Global Tissue-Based Diagnostics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Tissue-Based Diagnostics Revenue, 2018-2029
        6.3.2 US Tissue-Based Diagnostics Market Size, 2018-2029
        6.3.3 Canada Tissue-Based Diagnostics Market Size, 2018-2029
        6.3.4 Mexico Tissue-Based Diagnostics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Tissue-Based Diagnostics Revenue, 2018-2029
        6.4.2 Germany Tissue-Based Diagnostics Market Size, 2018-2029
        6.4.3 France Tissue-Based Diagnostics Market Size, 2018-2029
        6.4.4 U.K. Tissue-Based Diagnostics Market Size, 2018-2029
        6.4.5 Italy Tissue-Based Diagnostics Market Size, 2018-2029
        6.4.6 Russia Tissue-Based Diagnostics Market Size, 2018-2029
        6.4.7 Nordic Countries Tissue-Based Diagnostics Market Size, 2018-2029
        6.4.8 Benelux Tissue-Based Diagnostics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Tissue-Based Diagnostics Revenue, 2018-2029
        6.5.2 China Tissue-Based Diagnostics Market Size, 2018-2029
        6.5.3 Japan Tissue-Based Diagnostics Market Size, 2018-2029
        6.5.4 South Korea Tissue-Based Diagnostics Market Size, 2018-2029
        6.5.5 Southeast Asia Tissue-Based Diagnostics Market Size, 2018-2029
        6.5.6 India Tissue-Based Diagnostics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Tissue-Based Diagnostics Revenue, 2018-2029
        6.6.2 Brazil Tissue-Based Diagnostics Market Size, 2018-2029
        6.6.3 Argentina Tissue-Based Diagnostics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Tissue-Based Diagnostics Revenue, 2018-2029
        6.7.2 Turkey Tissue-Based Diagnostics Market Size, 2018-2029
        6.7.3 Israel Tissue-Based Diagnostics Market Size, 2018-2029
        6.7.4 Saudi Arabia Tissue-Based Diagnostics Market Size, 2018-2029
        6.7.5 UAE Tissue-Based Diagnostics Market Size, 2018-2029
7 Tissue-Based Diagnostics Companies Profiles
    7.1 Roche
        7.1.1 Roche Company Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Tissue-Based Diagnostics Major Product Offerings
        7.1.4 Roche Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.1.5 Roche Key News & Latest Developments
    7.2 Danaher
        7.2.1 Danaher Company Summary
        7.2.2 Danaher Business Overview
        7.2.3 Danaher Tissue-Based Diagnostics Major Product Offerings
        7.2.4 Danaher Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.2.5 Danaher Key News & Latest Developments
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Company Summary
        7.3.2 Thermo Fisher Scientific Business Overview
        7.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Major Product Offerings
        7.3.4 Thermo Fisher Scientific Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.3.5 Thermo Fisher Scientific Key News & Latest Developments
    7.4 Abbott
        7.4.1 Abbott Company Summary
        7.4.2 Abbott Business Overview
        7.4.3 Abbott Tissue-Based Diagnostics Major Product Offerings
        7.4.4 Abbott Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.4.5 Abbott Key News & Latest Developments
    7.5 Agilent Technologies
        7.5.1 Agilent Technologies Company Summary
        7.5.2 Agilent Technologies Business Overview
        7.5.3 Agilent Technologies Tissue-Based Diagnostics Major Product Offerings
        7.5.4 Agilent Technologies Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.5.5 Agilent Technologies Key News & Latest Developments
    7.6 ABCAM
        7.6.1 ABCAM Company Summary
        7.6.2 ABCAM Business Overview
        7.6.3 ABCAM Tissue-Based Diagnostics Major Product Offerings
        7.6.4 ABCAM Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.6.5 ABCAM Key News & Latest Developments
    7.7 Merck
        7.7.1 Merck Company Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Tissue-Based Diagnostics Major Product Offerings
        7.7.4 Merck Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.7.5 Merck Key News & Latest Developments
    7.8 BD
        7.8.1 BD Company Summary
        7.8.2 BD Business Overview
        7.8.3 BD Tissue-Based Diagnostics Major Product Offerings
        7.8.4 BD Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.8.5 BD Key News & Latest Developments
    7.9 Hologic
        7.9.1 Hologic Company Summary
        7.9.2 Hologic Business Overview
        7.9.3 Hologic Tissue-Based Diagnostics Major Product Offerings
        7.9.4 Hologic Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.9.5 Hologic Key News & Latest Developments
    7.10 Bio Rad
        7.10.1 Bio Rad Company Summary
        7.10.2 Bio Rad Business Overview
        7.10.3 Bio Rad Tissue-Based Diagnostics Major Product Offerings
        7.10.4 Bio Rad Tissue-Based Diagnostics Revenue in Global Market (2018-2023)
        7.10.5 Bio Rad Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Tissue-Based Diagnostics Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?